SAN FRANCISCO, Nov. 4, 2019 (FIERCEPHARMA) – Are more drugs really the answer to unlocking precision medicine? New focus that prioritizes patient profiling is likely to have major impact.
By Kevin Flanagan, PhD PD-1 and PD-L1 inhibitors have growing importance in cancer treatment. Many tumors express PD-L1, a cell surface protein that binds to PD-1. PD-1 is expressed by T cells, [...]
Cofactor Genomics Opens Early Access to New T Cell Exhaustion Models through Predictive Immune Modeling Platform
— Announces “Functional to FFPE” Early-Access Grant Program — San Francisco — November 6, 2019 (REPORTABLE) — Cofactor Genomics, leaders in RNA-based technologies and [...]